These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 1382938)

  • 1. Indobufen. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in cerebral, peripheral and coronary vascular disease.
    Wiseman LR; Fitton A; Buckley MM
    Drugs; 1992 Sep; 44(3):445-64. PubMed ID: 1382938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indobufen: an updated review of its use in the management of atherothrombosis.
    Bhana N; McClellan KJ
    Drugs Aging; 2001; 18(5):369-88. PubMed ID: 11392445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chronic treatment of vascular diseases with indobufen].
    Belcaro G; Errichi BM; Laurora G; Marinucci R; Cesarone MR; De Cenzo A
    Minerva Cardioangiol; 1989 May; 37(5):241-50. PubMed ID: 2779803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of antiplatelet therapy with indobufen or aspirin-dipyridamole on graft patency one year after coronary artery bypass grafting.
    Rajah SM; Nair U; Rees M; Saunders N; Walker D; Williams G; Critchley A; Beton D; Campbell C; Lawson RA
    J Thorac Cardiovasc Surg; 1994 Apr; 107(4):1146-53. PubMed ID: 8159037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indobufen compared with aspirin and dipyridamole on graft patency after coronary artery bypass surgery: results of a combined analysis.
    Cataldo G; Heiman F; Lavezzari M; Marubini E
    Coron Artery Dis; 1998; 9(4):217-22. PubMed ID: 9649928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of aspirin and indobufen in healthy volunteers.
    Lee JY; Sung KC; Choi HI
    Platelets; 2016; 27(2):105-9. PubMed ID: 26083594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiplatelet activity and tolerance of indobufen (K3920) in cerebrovascular disease: a therapeutic approach.
    Carrieri P; Orefice G; La Pia S; Indaco A; D'Acunio F; Iadevaia V
    Pharmatherapeutica; 1983; 3(6):410-6. PubMed ID: 6353432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacodynamic effects of indobufen compared with aspirin in patients with coronary atherosclerosis.
    Yang M; Ye Z; Mei L; Ullah I; Tan C; Wang G; Gu Q; Lu Y; Abdus S; Shi L; Gong X; Bai J; Eikelboom JW; Li C
    Eur J Clin Pharmacol; 2021 Dec; 77(12):1815-1823. PubMed ID: 34331551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term evaluation of indobufen in peripheral vascular disease.
    Belcaro G; De Simone P
    Angiology; 1991 Jan; 42(1):8-14. PubMed ID: 1992862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of indobufen on occlusion of arteriovenous fistulas and some platelet activity in intermittent peritoneal dialysis patients.
    Dmoszyńska A; Janicki K; Janicka L; Przesmycki K; Sokołowska B; Walter-Croneck A
    Pol J Pharmacol; 1996; 48(3):327-9. PubMed ID: 9112671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The d-enantiomer form of indobufen totally accounts for the anti-cyclooxygenase and antiplatelet activity ex vivo and for the increase in bleeding time by indobufen in man.
    De Caterina R; Sicari R; Yan A; Bernini W; Giannessi D; Lazzerini G; Efthymiopoulos C; Strolin-Benedetti M
    Thromb Haemost; 1992 Feb; 67(2):258-63. PubMed ID: 1621247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term antiplatelet activity and safety of indobufen in patients with cardiovascular disease. Italian Multicenter Study Group.
    Int J Clin Pharmacol Ther Toxicol; 1985 Aug; 23(8):439-46. PubMed ID: 3899952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the cyclo-oxygenase inhibitor indobufen on platelet accumulation in prosthetic vascular grafts.
    Lane IF; Irwin JT; Jennings SA; Poskitt KR; Meek AC; McCollum CN
    Br J Surg; 1986 Jul; 73(7):563-5. PubMed ID: 3730789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial comparing ticlopidine hydrochloride with indobufen for the prevention of stroke in high-risk patients (TISS Study). Ticlopidine Indobufen Stroke Study.
    Bergamasco B; Benna P; Carolei A; Rasura M; Rudelli G; Fieschi C
    Funct Neurol; 1997; 12(1):33-43. PubMed ID: 9127122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A randomized controlled trial of indobufen versus aspirin in the prevention of bridging restenosis after coronary artery bypass grafting].
    Bai C; Li JX; Yu Y; Liu R; Gao MX; Zhang F; Li HY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2022 May; 50(5):466-470. PubMed ID: 35589595
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effect of indobufen on platelet function and dialyzer regeneration in patients on hemodialysis].
    Sokołowska B; Dmoszyńska A; Janicka L; Walter-Croneck A
    Pol Arch Med Wewn; 1995 Jun; 93(6):475-82. PubMed ID: 7491347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of indobufen on patency in femoro-popliteal/crural bypass using artificial grafts].
    Cernak I; Lotina S; Davidović L
    Vojnosanit Pregl; 1994; 51(3):214-9. PubMed ID: 8560834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of indobufen on aortocoronary bypass patency after 1 week and after 1 year].
    Rohn V; Pirk J; Mach T
    Cor Vasa; 1993; 35(4):162-4. PubMed ID: 8403942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clopidogrel plus indobufen in acute coronary syndrome patients with hypersensitivity to aspirin undergoing percutaneous coronary intervention.
    Barillà F; Pulcinelli FM; Mangieri E; Torromeo C; Tanzilli G; Dominici T; Pellicano M; Paravati V; Acconcia MC; Gaudio C
    Platelets; 2013; 24(3):183-8. PubMed ID: 22646157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indobufen in secondary prevention of transient ischaemic attack. Multicentre Ischaemic Attack Study Group.
    Rogan J
    J Int Med Res; 1990; 18(3):240-4. PubMed ID: 2193837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.